706786-41-6 Usage
Uses
Used in Pharmaceutical Synthesis:
3,5-Difluoro-4-methoxybenzyl alcohol is used as an intermediate in the synthesis of pharmaceuticals, contributing to the development of new drugs and medicines. Its unique properties allow it to be a key component in the creation of various medicinal compounds.
Used in Agrochemical Production:
In the agrochemical industry, 3,5-Difluoro-4-methoxybenzyl alcohol serves as an intermediate, playing a crucial role in the synthesis of pesticides and other agricultural chemicals. Its involvement in these processes helps to enhance crop protection and yield.
Used as a Reagent in Organic Synthesis:
3,5-Difluoro-4-methoxybenzyl alcohol is utilized as a reagent in organic synthesis, where it aids in various chemical reactions. Its properties make it suitable for use in the preparation of complex organic molecules.
Used as a Building Block in Chemical Compound Production:
3,5-DIFLUORO-4-METHOXYBENZYL ALCOHOL also functions as a building block for the production of a range of chemical compounds, expanding its applications across different chemical industries.
Used in Research Applications:
3,5-Difluoro-4-methoxybenzyl alcohol is employed in research settings for its ability to act as a mild reducing agent, facilitating specific reactions and experiments in organic chemistry. Its presence in research helps to advance scientific understanding and innovation in the field.
Check Digit Verification of cas no
The CAS Registry Mumber 706786-41-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,0,6,7,8 and 6 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 706786-41:
(8*7)+(7*0)+(6*6)+(5*7)+(4*8)+(3*6)+(2*4)+(1*1)=186
186 % 10 = 6
So 706786-41-6 is a valid CAS Registry Number.
706786-41-6Relevant academic research and scientific papers
PHARMACEUTICAL COMPOSITION COMPRISING A PYRAZOLE-O-GLUCOSIDE DERIVATIVE
-
Page/Page column 48, (2008/12/07)
The invention relates toa pharmaceutical composition comprising a pyrazole-O-glucoside derivative selected from the group of compounds (1) to (29) according to claim 1 in combination with at least one second therapeutic agent which is suitable in the trea
METHODS FOR PREVENTING AND TREATING METABOLIC DISORDERS AND NEW PYRAZOLE-O-GLYCOSIDE DERIVATIVES
-
Page/Page column 34, (2010/11/25)
The invention relates to methods for preventing or treating metabolic disorders, for improving glycemic control, for preventing progression from impaired glucose tolerance, insulin resistance and/or from metabolic syndrome to type 2 diabetes mellitus, for
